Sponsor:
Obsidian Therapeutics, Inc.
Code:
NCT06060613
Conditions
Tumor Skin
Metastatic Melanoma
Melanoma
Lung Cancer
Metastatic Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
OBX-115
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-18. This information was provided to ClinicalTrials.gov by Obsidian Therapeutics, Inc. on 2025-08-29.